BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 12212196)

  • 61. Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat.
    Sahin K; Onderci M; Tuzcu M; Ustundag B; Cikim G; Ozercan IH; Sriramoju V; Juturu V; Komorowski JR
    Metabolism; 2007 Sep; 56(9):1233-40. PubMed ID: 17697867
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Experimental diabetes induced by alloxan and streptozotocin: The current state of the art.
    Radenković M; Stojanović M; Prostran M
    J Pharmacol Toxicol Methods; 2016; 78():13-31. PubMed ID: 26596652
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Toxin-induced IDDM (insulin dependent diabetes mellitus) in the musk shrew.
    Ohno T; Kitoh J; Yamashita K; Ichikawa Y; Horio F; Terada M; Tanaka S; Namikawa T
    Life Sci; 1998; 63(6):455-62. PubMed ID: 9718069
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Induction of experimental diabetes in frog (author's transl)].
    Castiñeiras MJ; Boronat A; Itarte E; Guinovart JJ; Rosell-Pérez M
    Rev Esp Fisiol; 1978 Dec; 34(4):385-8. PubMed ID: 154157
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Drug-induced animal models of diabetes].
    Iwashima Y
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():47-51. PubMed ID: 12355793
    [No Abstract]   [Full Text] [Related]  

  • 66. Pharmacokinetics of drugs in rats with diabetes mellitus induced by alloxan or streptozocin: comparison with those in patients with type I diabetes mellitus.
    Lee JH; Yang SH; Oh JM; Lee MG
    J Pharm Pharmacol; 2010 Jan; 62(1):1-23. PubMed ID: 20722995
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Spontaneous and experimental models of human juvenile diabetes mellitus].
    Korec R
    Cesk Pediatr; 1989 May; 44(5):263-7. PubMed ID: 2752453
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Free-radical theory of etiopathogenesis of insulin-dependent diabetes mellitus].
    Ciechanowski K; Machoy Z
    Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):48-50. PubMed ID: 1409043
    [No Abstract]   [Full Text] [Related]  

  • 69. Mortality and renal failure in the streptozocin-alloxan diabetic dog attributed to contamined alloxan preparations.
    Cutfield R; Albu DS; Chan IF; Moatamed F; Peric-Golia L; Wilson DE
    Horm Metab Res; 1984 Oct; 16(10):549-50. PubMed ID: 6500490
    [No Abstract]   [Full Text] [Related]  

  • 70. Experimentally induced rodent models of type 2 diabetes.
    Islam MS; Wilson RD
    Methods Mol Biol; 2012; 933():161-74. PubMed ID: 22893406
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pre-clinical investigation of Diabetes Mellitus as a risk factor for schizophrenia.
    Heylmann ASA; Canever L; Gress K; Gomes ST; Fachim I; Michels C; Stopassoli GC; Mastella GA; Steckert AV; Damiani AP; de Andrade VM; Quevedo J; Zugno AI
    Behav Brain Res; 2017 May; 326():154-164. PubMed ID: 28286284
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Some lessons from experimental diabetes mellitus.
    J Assoc Physicians India; 1978 Sep; 26(9):850-2. PubMed ID: 154507
    [No Abstract]   [Full Text] [Related]  

  • 73. [Morphology of the skeletal musculature in alloxan diabetes].
    Titova GP; Khotenashvili NV
    Biull Eksp Biol Med; 1988 Apr; 105(4):504-6. PubMed ID: 3359041
    [No Abstract]   [Full Text] [Related]  

  • 74. [Streptozocin-induced diabetes].
    Iwashima Y
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():732-7. PubMed ID: 9513505
    [No Abstract]   [Full Text] [Related]  

  • 75. 1,10 phenanthroline, a metal chelator, protects against alloxan- but not streptozotocin-induced diabetes.
    Eizirik DL; de Lúcio MA; Boschero AC; Hoffmann ME
    J Free Radic Biol Med; 1986; 2(3):189-92. PubMed ID: 3033047
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Strategies for preclinical pharmacokinetic investigation in streptozotocin-induced diabetes mellitus (DMIS) and alloxan-induced diabetes mellitus (DMIA) rat models: case studies and perspectives.
    Srinivas NR
    Eur J Drug Metab Pharmacokinet; 2015 Mar; 40(1):1-12. PubMed ID: 24596068
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Problems in producing alloxan diabetes.
    Pemberton LB; Manax WG
    Surgery; 1970 Aug; 68(2):375-8. PubMed ID: 5450719
    [No Abstract]   [Full Text] [Related]  

  • 78. Streptozotocin induced diabetes in minipig: a case report of a possible model for type 1 diabetes?
    Rolandsson O; Haney MF; Hagg E; Biber B; Lernmark A
    Autoimmunity; 2002 Jul; 35(4):261-4. PubMed ID: 12482194
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Study of the pathogenesis and treatment of diabetes mellitus through animal models.
    Brito-Casillas Y; Melián C; Wägner AM
    Endocrinol Nutr; 2016; 63(7):345-53. PubMed ID: 27246633
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The mechanisms of alloxan- and streptozotocin-induced diabetes.
    Lenzen S
    Diabetologia; 2008 Feb; 51(2):216-26. PubMed ID: 18087688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.